Bioferon Indications/Uses

The use of rHulFNα2-Sidus can be indicated in: Virology: Clinical entities of viral etiology.
Human papillomavirus: Common warts, condylomata acuminatum located in penis, perineal region, anus, rectum, vulva, vagina, cervix, cervical, dysplastic entities associated to human papillomavirus, respiratory tract papillomatosis, epidermodysplasia verruciformis, bladder papilloma.
Hepatitis Virus: Chronic hepatitis caused by hepatitis C virus and hepatitis B virus.
INTERFERON ALPHA induces inhibition of hepatitis B viral replication for long periods.
Inhibition takes place in hepatocites that contain virus in active replication.
Viral infections in patients with: Congenital immuno-suppression syndrome acquired immuno-depression syndrome (AIDS): Chemotherapy in neoplastic disease therapy; chemotherapy or corticoid therapy in patients with renal transplant or other grafts.
Oncology: Malignant melanoma; Kaposi's sarcoma associated to AIDS, renal cancer; carcinoid tumor; in situ carcinoma or the cervix associated AIDS.
Oncohaematology: Hairy cell leukemia, non-Hodgkin lymphoma, T-cell cutaneous lymphoma, multiple myeloma, chronic granulocyte leukemia.